Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Halofuginone efficacy and pharmacokinetic data presented at ASCO

June 11, 2003

Good safety profile for peginterferon alfa-2a in malignant melanoma

June 11, 2003

MEDI-522 well tolerated in patients with refractory colorectal cancer

June 11, 2003

CC-5013 inhibits adhesion molecules and prevents metastasis in an animal model

June 11, 2003

Phase III trial update on six-month Eligard product

June 10, 2003

Ganymed and U. of Ghent come together for target validation

June 10, 2003

ImClone and BMS discuss Erbitux regulatory filing with FDA

June 10, 2003

Evidence of antitumor effects reported for ZD-6474 in refractory solid tumors

June 10, 2003

Good toxicity profile for CEP-7055 in patients with incurable solid tumors

June 10, 2003

CEP-701 reported to induce antitumoral effects in refractory AML

June 10, 2003

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...